Article and Video CATEGORIES
ALERT: The links for the podcasts are now fixed.
Here's the question and answer session with Drs. Mary Pinder and Nasser Hanna following their presentations on the lung cancer highlights from the ASCO 2011 annual meeting (Dr. Pinder's on SCLC, early stage NSCLC, and mesothelioma here, and Dr. Hanna's on advanced NSCLC here), covering a lot of ground on timely issues raised from the conference. The program and podcast were developed in partnership with LUNGevity Foundation.
Below is the audio and video versions of the podcast, as well as the transcript and figures.
But if that list of questions and answers doesn't cover every question YOU have in response to the ASCO presentations, feel free to ask the stragglers here.
Please feel free to offer comments and raise questions in our
Next Previous linkPrevious PostNext Post
Hi Caregiver and welcome to Grace. I'm sorry that you need to be here and hope we can help. Osimertinib has better efficacy than gefitinib (including OS and reaching the brain)...
Hi Bob, Welcome to Grace. I'm sorry about your sil. Unfortunately, cancer becomes resistant to TKIs like tagrisso. Sometimes all of the cancer becomes resistant at once and sometimes just parts...